These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7229622)

  • 21. Failure to detect infectious hepatitis B virus using high dose safety test for hepatitis B vaccine.
    Tabor E; Barker LF; Gerety RJ
    J Med Virol; 1981; 6(4):279-84. PubMed ID: 7241095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
    Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
    Celis E; Kung PC; Chang TW
    J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
    Oka Y; Akbar SM; Horiike N; Joko K; Onji M
    Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant.
    Li P; Tan H; Xu D; Yin F; Cheng Y; Zhang X; Liu Y; Wang F
    Carbohydr Polym; 2014 Sep; 110():446-55. PubMed ID: 24906778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of skin reaction to hepatitis B vaccines in man.
    Nagafuchi S; Kashiwagi S; Inoue T; Imayama S
    Microbiol Immunol; 1984; 28(2):257-9. PubMed ID: 6233475
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
    Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
    J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immunity to hepatitis B surface antigen in man.
    Hanson RG; Hoofnagle JH; Minuk GY; Purcell RH; Gerin JL
    Clin Exp Immunol; 1984 Aug; 57(2):257-64. PubMed ID: 6235987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
    Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
    Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium.
    Woo PC; Wong LP; Zheng BJ; Yuen KY
    Vaccine; 2001 Apr; 19(20-22):2945-54. PubMed ID: 11282206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres.
    Dentico P; Crovari P; Lai PL; Ponzio F; Safary A; Pellegrino A; Meurice F; Di Pasquale A; Tornieporth N; Volpe A; Icardi G
    Vaccine; 2002 Nov; 20(31-32):3725-30. PubMed ID: 12399201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.